CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Income Statement
NASDAQ:CLOV - US18914F1030 - Common Stock
2.62 USD
-0.01 (-0.38%)
2.61 USD
-0.01 (-0.38%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.61B | 1.37B | 1.26B | 3.48B | 1.47B | |||
| Operating Expenses | 1.65B | 1.42B | 1.44B | 3.85B | 2.11B | |||
| Selling, General, and Administrative Expenses | 424.71M | 408.93M | 440.25M | 486.60M | 445.70M | |||
| Operating Income | -42.60M | -45.46M | -179.56M | -370.90M | -637.00M | |||
| Interest Income/Expense | 0.00 | -467.00K | -4.73M | 8.80M | 62.90M | |||
| Other Income/Expense | N/A | -50.00K | -86.00K | 0.00 | -13.70M | |||
| Non Recurring Items | 538.00K | -288.00K | -25.77M | 23.30M | N/A | |||
| Income Before Taxes | -42.12M | -46.27M | -210.15M | -338.80M | -587.80M | |||
| Net Income | -43.10M | -43.01M | -213.36M | -338.80M | -587.80M | |||
| EBITDA | -41.06M | -44.13M | -177.05M | -369.71M | -635.75M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.44 | -0.71 | -1.42 | |||
| Non GAAP EPS | -0.08 | -0.09 | -0.44 | -0.74 | -1.27 | |||
| Statistics | ||||||||
| Profit Margin | -2.68% | -3.14% | -16.93% | -9.74% | -39.93% | |||
| Operating Profit Margin | -2.65% | -3.32% | -14.24% | -10.67% | -43.27% | |||
All data in USD